PDAPP;: YFP double transgenic mice:: A tool to study antyloid-β associated changes in axonal, dendritic, and synaptic structures

被引:52
作者
Brendza, RP
O'Brien, C
Simmons, K
McKeel, DW
Bales, KR
Paul, SM
Olney, JW
Sanes, JR
Holtzman, DM
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA
[7] Eli Lilly & Co, Neurosci Discovery Res, Indianapolis, IN 46285 USA
[8] Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46285 USA
[9] Indiana Univ, Sch Med, Dept Toxicol, Indianapolis, IN 46285 USA
[10] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46285 USA
[11] Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA
关键词
Alzheimer's disease; neuritic dystrophy; silver stain; fluorescent protein;
D O I
10.1002/cne.10536
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuritic plaques are one of the stereotypical hallmarks of Alzheimer's disease (AD) pathology. These structures are composed of extracellular accumulations of fibrillar forms of the amyloid-beta peptide (Abeta), a variety of other plaque-associated proteins, activated glial cells, and degenerating nerve processes. To study the neuritic toxicity of different structural forms of Abeta in the context of regional connectivity and the entire cell, we crossed PDAPP transgenic (Tg) mice, a model with AD-like pathology, to Tg mice that stably express yellow fluorescent protein (YFP) in a subset of neurons in the brain. In PDAPP; YFP double Tg mice, markedly enlarged YFP-labeled axonal and dendritic varicosities were associated with fibrillar Abeta deposits. These varicosities were absent in areas where there were nonfibrillar Abeta deposits. Interestingly, YFP-labeled varicosities revealed changes that corresponded with changes seen with electron microscopy and the de Olmos silver staining technique. Other silver staining methods and immunobistochemical localization of phosphorylated neurofilaments or phosphorylated tau were unable to detect the majority of these dystrophic neurites. Some but not all synaptic vesicle markers accumulated abnormally in YFP-labeled varicosities associated with neuritic plaques. In addition to the characterization of the effects of Abeta on axonal and dendritic structure, YFP-labeled neurons in Tg mice should prove to be a valuable tool to interpret the localization patterns of other markers and for future studies examining the dynamics of axons and dendrites in a variety of disease conditions in living tissue both in vitro and in vivo. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 34 条
  • [1] Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
    Backskai, BJ
    Kajdasz, ST
    Christie, RH
    Carter, C
    Games, D
    Seubert, P
    Schenk, D
    Hyman, BT
    [J]. NATURE MEDICINE, 2001, 7 (03) : 369 - 372
  • [2] Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
    Bales, KR
    Verina, T
    Dodel, RC
    Du, YS
    Altstiel, L
    Bender, M
    Hyslop, P
    Johnstone, EM
    Little, SP
    Cummins, DJ
    Piccardo, P
    Ghetti, B
    Paul, SM
    [J]. NATURE GENETICS, 1997, 17 (03) : 263 - 264
  • [3] Clinicopathologic studies in cognitively healthy aging and Alzheimer disease - Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
    Berg, L
    McKeel, DW
    Miller, JP
    Storandt, M
    Rubin, EH
    Morris, JC
    Baty, J
    Coats, M
    Norton, J
    Goate, AM
    Price, JL
    Gearing, M
    Mirra, SS
    Saunders, AM
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (03) : 326 - 335
  • [4] Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections
    Braak, Heiko
    Braak, Eva
    [J]. BRAIN PATHOLOGY, 1991, 1 (03) : 213 - 216
  • [5] BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284
  • [6] CAVALIERI B, 1966, GEOMETRIA DEGLI INDI
  • [7] Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
    Cummings, JL
    Vinters, HV
    Cole, GM
    Khachaturian, ZS
    [J]. NEUROLOGY, 1998, 51 (01) : S2 - S17
  • [8] Plaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer's disease
    DeMattos, RB
    Bales, KR
    Parsadanian, M
    O'Dell, MA
    Foss, EM
    Paul, SM
    Holtzman, DM
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) : 229 - 236
  • [9] Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP
    Feng, GP
    Mellor, RH
    Bernstein, M
    Keller-Peck, C
    Nguyen, QT
    Wallace, M
    Nerbonne, JM
    Lichtman, JW
    Sanes, JR
    [J]. NEURON, 2000, 28 (01) : 41 - 51
  • [10] ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN
    GAMES, D
    ADAMS, D
    ALESSANDRINI, R
    BARBOUR, R
    BERTHELETTE, P
    BLACKWELL, C
    CARR, T
    CLEMENS, J
    DONALDSON, T
    GILLESPIE, F
    GUIDO, T
    HAGOPIAN, S
    JOHNSONWOOD, K
    KHAN, K
    LEE, M
    LEIBOWITZ, P
    LIEBERBURG, I
    LITTLE, S
    MASLIAH, E
    MCCONLOGUE, L
    MONTOYAZAVALA, M
    MUCKE, L
    PAGANINI, L
    PENNIMAN, E
    POWER, M
    SCHENK, D
    SEUBERT, P
    SNYDER, B
    SORIANO, F
    TAN, H
    VITALE, J
    WADSWORTH, S
    WOLOZIN, B
    ZHAO, J
    [J]. NATURE, 1995, 373 (6514) : 523 - 527